A large study found that more screen time in late childhood was linked to higher depression scores in early adolescence, with shorter sleep and changes in brain white matter helping explain the connection.
A large US-based study found that people with celiac disease, hyperthyroidism, or hypothyroidism face a two- to threefold increased risk of developing type 1 diabetes, with the highest risk seen in children.
Tyzavan is the first FDA-approved vancomycin formulation available at room temperature that requires no compounding, thawing, or dilution, enabling faster treatment in time-critical infections like sepsis.
New research highlights strong associations between metabolic syndrome and several oral diseases—including periodontitis, caries, and peri-implantitis—calling for more longitudinal studies to explore causation and improve patient care.
Climate change, wildfire aftermath, and lack of a reliable vaccine raise concerns that dengue may become endemic in parts of the U.S. as mosquito season intensifies.
Atsena Therapeutics’ founder and chief scientific officer discusses her role as CSO, the latest developments with ATSN-101, trends in the ocular gene therapy space, and more.